168
Views
21
CrossRef citations to date
0
Altmetric
Original Article

Kinetics of B-type natriuretic peptide plasma levels in patients with left-sided breast cancer treated with radiation therapy: Results after one-year follow-up

, , , , , , , , & show all
Pages 804-809 | Received 14 Nov 2013, Accepted 05 Mar 2015, Published online: 14 May 2015

References

  • Andratschke N, Maurer J, Molls M, Trott KR. 2011. Late radiation- induced heart disease after radiotherapy. Clinical importance, radiobiological mechanisms and strategies of prevention. Radiat Oncol 100:160–166.
  • Darby SC, Cutter DJ, Boerma M, Costine LS, Fajardo LF, Kodama K, Mabuchi K, Marks LB, Mettler FA, Pierce LJ, Trott KR, Yeh ETH, Shore RE. 2010. Radiation-related heart disease: Current knowledge and future prospects. Int J Radiat Oncol Biol Phys 76:656–665.
  • Darby S, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Brønnum D, Correa C, Cutter D, Gagliardi G, Gigante B, Jensen M, Nisbet A, Peto R, Pahimi K, Taylor C, Hall P. 2013. Risk of ischemic heart disease in women after Radiotherapy for breast cancer. N Engl J Med 368:987–998.
  • D’Errico MP, Grimaldi L, Petruzzelli MF, Gianicolo EAL, Tramacere F, Monetti A, Placella R, Pili G, Andreassi MG, Sicari R, Picano E, Portaluri M. 2012. NT-proBNP plasma levels as a potential biomarker for cardiac damage after radiotherapy in left-sided breast cancer patients. Int J Radiat Oncol Biol Phys 82:e239–246.
  • Edmin M, Passino C, Prontera C, Fontana M, Poletti R, Gabutti A, Mammini C, Giannoni A, Zyw L, Zucchelli G, Clerico A. 2007. Comparison of brain natriuretic peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure. Clin Chem 53:1289–1297.
  • Erven K, Jucurt R, Weltens C, Giusca S, Ector J, Wildiers H, Van den Bogaert W, Voigt JU. 2011. Acute radiation effects on cardiac function detected by strain rate imaging in breast cancer patients. Int J Radiat Oncol Biol Phys 79:1444–1451.
  • Evangelista A, Flachskampf F, Lancellotti P, Badano L, Aguilar R, Monaghan M, Zamorano J, Nihoyannopoulos P. 2008. European Association of Echocardiography recommendations for standardization of performance, digital storage and reporting of echocardiographic studies. Eur J Echocardiogr 9:438–448.
  • Gagliardi G, Constine LS, Moiseenko V, Correa C, Pierce LJ, Allen AM, Marks LB. 2010. Radiation dose-volume effects in the heart. Int J Radiat Oncol Biol Phys 76:S77–85.
  • Hall KS, Wiklund T, Erikstein B, Holte H, Kvalheim G, Henn Sommer H, Andersen A, Skovlund E, Bergh J, Hall C. 2001. Effects of dose- intensive chemotherapy and radiotherapy on serum n-terminal proatrial natriuretic peptide in high risk breast cancer patients. Breast Cancer Res Treat 67:235–244.
  • Hughes-Davies L, Sacks D, Rescigno J, Howard S, Harris J. 1995. Serum cardiac troponin T levels during treatment of early-stage breast cancer. J Clin Oncol 13:2582–2584.
  • Huntley BK, Sandberg SM, Noser JA, Cataliotti A, Redfield MM, Matsuda Y, Burnett JC. 2006. BNP-induced activation of cGMP in human cardiac fibroblasts: Interactions with fibronectin and natriuretic peptide receptors. J Cell Physiol 209:943–949.
  • International Commission on Radiation Units and Measurements (ICRU). 2010. Prescribing, recording, and reporting photon beam therapy. Report 83, Bethesda, MD: ICRU.
  • Jingu K, Nemoto K, Kaneta T, Oikawa M, Ogawa Y, Ariga H, Takeda K, Sakayauchi T, Fujimoto k, Narazaki K, Takai Y, Nakata E, Fokuda H, Takahashi S, Yamada S. 2007. Temporal change in brain natriuretic peptide after radiotherapy for thoracic esophageal cancer. Int J Radiat Oncol Biol Phys 69:1417–1423.
  • Kapoun AM, Liang F, O’Young G, Damm DL, Quon D, White RT, Munson K, Lam A, Schreiner GF, Protter AA. 2004. B-type natriuretic peptide exerts broad functional opposition to Transforming Growth Factor-b in primary human cardiac fibroblast: Fibrosis, myofibroblast conversion, proliferation, and inflammation. Circ Res 94:453–461.
  • Kozak KR, Hong TS, Sluss PM, Lewandrowski EL, Aleryani SL, Macdonald SM, Choi NC, Yock TI. 2008. Cardiac blood biomarkers in patients receiving thoracic (chemo)radiation. Lung Cancer 62:351–355.
  • Marks LB, Yu X, Proznitz RG, Zhou S, Hardenbergh PH, Blazing M, Hollis D, Lind P, Tisch A, Wong TZ, Borges-Neto S. 2005. The incidence and functional consequences of RT-associated cardiac perfusion defects Int J Radiat Oncol Biol Phys 63:214–223.
  • Nellessen U, Zingel M, Hecker H, Bahnsen J, Borschke D. 2010. Effects of radiation therapy on myocardial cell integrity and pump function: Which role for cardiac biomarkers? Chemotherapy 56:147–152.
  • Perik PJ, De Vries EGE, Boomsma F, Van Der Graaf WTA, Sleijfer DT, Van Veldhuise DJ, Gietema JA. 2005. Use of natriuretic peptides for detecting cardiac dysfunction in long-term disease-free breast cancer survivors. Anticancer Res 25:3651–3657.
  • Prosnitz RG, Marks LB. 2005. Radiation-induced heart disease: Vigilance is still required. J Clin Oncol 23:7391–7394.
  • Prosnitz RG, Hubbs JL, Evans ES, Zhou SM, Yu X, Blazing MA, Hollis DR, Tisch A, Wong TZ, Borges-Neto S, Handerbergh PH, Marks LB. 2007. Prospective assessment of radiotherapy-associated cardiac toxicity in breast cancer patients: Analysis of data 3 to 6 years after treatment. Cancer 110:1840–1850.
  • Roychoudhuri R, Robinson D, Putcha V, Cuzick J, Darby S, Møller H. 2007. Increased cardiovascular mortality more than fifteen years after radiotherapy for breast cancer: A population-based study. BMC Cancer 7:9.
  • Sardaro A, Petruzzelli MF, D’Errico MP, Grimaldi L, Pili G, Portaluri M. 2012. Radiation-induced cardiac damage in early left breast cancer patients: Risk factors, biological mechanism, radiobiology and dosimetric constraints. Radiother Oncol 103:133–142.
  • SAS/STAT User's Guide. 1989. Version 6, 4th edition. Vol. 1 and 2. Cary NC: SAS Institute Inc.
  • Seddon B, Cook A, Gothard L, Salmon E, Latus K, Underwood SR, Yarnold J. 2002. Detection of defects in myocardial perfusion imaging in patients with early breast cancer treated with radiotherapy. Radiother Oncol 64:53–63.
  • Senkus-Konefka E, Jassem J. 2007. Cardiovascular effects of breast cancer radiotherapy. Cancer Treat Rev 33:578–593.
  • Stewart FA, Hoving S, Russell NS. 2010. Vascular damage as an underlying mechanism of cardiac and cerebral toxicity in irradiated cancer patients. Radiat Res 174:865–869.
  • Takahashi N, Calderone A, Izzo NJ Jr, Mäki TM, Marsh JD, Colucci WS. 1994. Hypertrophic stimuli induce transforming growth factor-β1 expression in rat ventricular myocites. J Clin Invest 94:1470–1476.
  • Tamura N, Ogawa Y, Chusho H, Nakamura K, Nakao K, Suda M, Kasahara M, Hashimoto R, Katsuura G, Mukoyama M, Itoh H, Saito Y, Tanaka I, Otani H, Katsuki M. 2000. Cardiac fibrosis in mice lacking brain natriuretic peptide. Proc Natl Acad Sci USA 97:4239–4244.
  • Tomita H, Egashira K, Ohara Y, Takemoto M, Koyanagi M, Katoh M, Yamamoto H, Tamaki K, Shimokawa H, Takeshita A. 1998. Early induction of transforming growth factor-β via angiotensin II type 1 receptors contributes to cardiac fibrosis induced by long-term blockade of nitric oxide synthesis in rats. Hypertension 32:273–279.
  • Tzonevska A, Tzvetkov K, Atanasova M, Chakarova A, Piperkova E. 2011. Myocardial scintigraphy, echocardiography and proBNP for early detection of myocardial cardiotoxicity in breast cancer patients after chemo-radiotherapy. Hell J Nucl Med 14:269–273.
  • Villarreal FJ, Dillmann WH. 1992. Cardiac hypertrophy-induced changes in mRNA levels for TGFβ1, fibronectin, and collagen. Am J Physiol 262:H1861–1866.
  • Wieshammer S, Dreihaupt J, Müller D, Momm F, Jakob A, Freund U. 2013. Cardiotoxicity and cancer therapy: Treatment-related cardiac morbidity in patients presenting with symptoms suggestive of heart or lung disease. Oncology 85:137–144.
  • Wondergerm J, Strootman EG, Frölich M, Leer JWH, Noordijk EM. 2001. Circulating atrial natriuretic peptide plasma levels as a marker for cardiac damage after radiotherapy. Radiother Oncol 58:295–301.
  • Wu A, Smith A, Wieczorek S, Mather JF, Duncan B, White CM, McGill C, Katten D, Heller G. 2003. Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure. Am J Cardiol 92:628–631.
  • Yarnold J, Brotons MC. 2010. Pathogenetic mechanisms in radiation fibrosis. Radiother Oncol 97:149–161.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.